https://pinboard.in/u:Michael.Massing/public/ recent bookmarks from Michael.Massing 2026-02-05T04:16:07+00:00 https://www.medpagetoday.com/infectiousdisease/rsv/119744?xid=nl_mpt_DHE_2026-02-04&mh=7beedf85be02817127aebdf9dcc93d42&zdee=gAAAAABm4vYY3ATH4iFowacPbWxqKDu5cITUhZkLc-pWE7cJHyZXCk0IubgPcT3ehIWBv65TRh84YLvoUjk40DTyydSFRhNuf3hQ3R9bIlV4bQAMMvQuEGs%253D Michael.Massingrisk cardiovascular cardiorespiratory stroke heart attack infarct MCI myocardial RSV vaccine infarction research human clnical trial ln vivo https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:bae1dde3e7f8/ 2023-12-30T22:38:45+00:00 https://www.nytimes.com/2023/04/04/well/eat/tofu-health-benefits.html?action=click&pgtype=Article&state=default&module=styln-ask-well&variant=show&region=BELOW_MAIN_CONTENT&block=storyline_flex_guide_recirc Michael.Massing soy nutrition diet risk benefit heart disease cardiovascular cancer mortality isoflavones https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:849e6139d686/ 2023-10-12T19:23:22+00:00 https://www.wsws.org/en/articles/2023/10/10/covi-o10.html Michael.Massingclinical cohort COVID19 human in mortality heart cardiovascular arteries plaque research retrospective risk treatment vivo https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:eda87666376a/ 2023-05-22T03:57:20+00:00 https://www.wired.com/story/aging-brain-volume/ Michael.Massing brain cardiovascular health risk benefit lifestyle culture BMI cholesterol blood lipids comparative physiology metabolism https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:e22e31e80619/ 2023-01-09T03:37:20+00:00 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018903/#__ffn_sectitle Michael.MassingCOVID19 cardiovascular symptoms complications effects comorbidities aortic pathology https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:e81e12231f82/ 2022-03-26T18:35:18+00:00 https://www.medpagetoday.com/neurology/dementia/97854?xid=nl_covidupdate_2022-03-25&eun=g894600d0r Michael.Massing0.05). Future development of Alzheimer's dementia was progressively higher and likely to occur earlier among people who had blood glucose in pre-diabetic (100 to 126 mg/dL) and diabetic (>126 mg/dL) ranges in early adulthood and middle adulthood. "Intervention targeting cholesterol and glucose management starting in early adulthood can help maximize cognitive health in later life," Farrer suggested.]]> Framingham longitudinal data risk Alzheimer's cardiovascular factors peer-reviewed research HDL high-density lipoprotein correlation cohort human in vivo prospective trial prevention intervention https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:1b2481ed6811/ 2021-12-16T03:23:08+00:00 https://academic.oup.com/eurjpc/advance-article/doi/10.1093/eurjpc/zwab189/6447088 Michael.Massing40%. Importantly, in this first and largest meta-analysis reviewing LVEF >50%, we show that this benefit is maintained, albeit to a lesser degree, in the cohort of patients with LVEF ≥50%. SGLT2i become in this way the first medication with potential for prognostic benefit in HFpEF. However, overall mortality was not improved in HFpEF, indicating that the other comorbidities associated with HFpEF play a significant role. In order to draw robust conclusions safely regarding these efficacy outcomes, further large trials need to evaluate the effect of the SGLT2 inhibitors in a sufficient number of patients with HFpEF. The various subphenotypes of HFpEF and its management have puzzled physicians for several years. The high rates of morbidity and mortality that it carries, along with the diagnostic and treatment challenges, have transformed it in one of the most challenging clinical entities. SGLT2i appear to provide some light and positivity, as their cardiometabolic profile impacts favourably on the complex pathophysiological mechanisms involved in HFpEF.9 However, the quest to untangle the complexity of treating HFpEF is certainly not over. We show conclusively that for LVEF 40–50% included as HFpEF in previous studies (but no longer considered HFpEF in the guidelines) there is a strong benefit from SGLT2i translating to reduced cardiovascular mortality and HHF, but not overall mortality. This also extended to the LVEF >50% but with a smaller effect. Additionally, while the vast majority of the patients included in this meta-analysis were individuals with diabetes at baseline, the cardioprotective benefits of the SGLT2i have been shown to occur via mechanisms independent of baseline diabetes status.10 Furthermore, the effect of SGLT2i in patients with reduced EF without diabetes is well-documented9,10 and EMPEROR-Preserved also included patients without diabetes, therefore their effect is applicable to patients without diabetes.]]> SGLT2 inhibitor risk benefit heart failure ejection fraction meta-analysis diabetes comorbidity cardiac cardiovascular protection peer-reviewed research https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:c3be4a0be53b/ 2021-10-25T01:20:04+00:00 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02188-7/fulltext Michael.Massing insulin glargine GIP GLP-1 receptor A1c Hb hemoglobin benefit risk cardiovascular peer-reviewed research clinical trial human in vivo https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:eb3838f4fd08/ 2021-09-21T02:51:49+00:00 https://www.endocrinologyadvisor.com/home/topics/diabetes/increased-risk-for-major-adverse-cardiovascular-events-with-insulin-in-patients-with-diabetes-and-acs/?NID=-1&cpn&email_hash=983917dd1eba78eb44e393fea65df5ca&hmEmail=Jw_YJjhVyI84iX-Oepu7iw7YiNSIB0EK31LP7LVx8w01&hmSubId=YY-zPItNrOw1&mpweb=1323-153862-7624403 Michael.Massingtreatment risk benefit insulin cardiovascular heart ACS acute coronary syndome peer-reviewed research in vivo human clinical trial https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:d28499eda07c/ 2021-09-11T17:32:03+00:00 https://www.heart.org/en/news/2020/04/20/as-marijuana-use-grows-researchers-want-to-know-how-it-affects-the-heart Michael.Massing cannabis marijuana recreational medicinal use heart cardiac effects cardiovascular blood pressure overview research clinical human in vivo population https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:d6305ad181c2/ 2021-08-25T17:28:16+00:00 https://www.endocrinologyadvisor.com/home/topics/diabetes/type-2-diabetes/weight-loss-and-cardiovascular-renal-benefit-with-sglt2-inhibitors-in-t2d/?hmSubId=YY-zPItNrOw1&hmEmail=Jw_YJjhVyI84iX-Oepu7iw7YiNSIB0EK31LP7LVx8w01&NID=-1&email_hash=983917dd1eba78eb44e393fea65df5ca&mpweb=1323-149900-7624403 Michael.Massing SGLT2 inhibitors peer-reviewed research human clinical trial review in vivo situ risk benefit diabetes treatment T2D type 2 kidney heart cardiovascular CVD genital infection necrosis diabetic ketoacidosis DKA https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:253b12fb0e87/ 2021-03-28T00:49:12+00:00 https://scholar.google.com/scholar?hl=en&as_sdt=0%2C7&as_vis=1&q=whole+grains+longevity+cardiovascular+cardiac+risk&btnG= Michael.Massing whole grains longevity cardiovascular cardiac risk benefit protection diet food foods https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:100c845abbb9/ 2020-09-27T17:44:12+00:00 https://care.diabetesjournals.org/content/28/11/2756 Michael.Massing FBG IFG impaired fasting blood glucose mortality CVD cardiovascular disease risk threshold diagnostic standards prediabetes diabetes all-cause peer-reviewed research in vivo human cohort study https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:117b43629584/ 2020-09-21T07:59:58+00:00 https://www.medpagetoday.org/infectiousdisease/uritheflu/88447?xid=nl_mpt_DHE_2020-09-04&eun=g894600d0r&vpass=1 Michael.Massing influenza flu cardiovascular risk events human retrospective in vivo cross-sectional peer-reviewed research https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:bfcd7be5b46b/ 2020-09-21T06:00:41+00:00 https://academic.oup.com/eurheartj/article/41/32/3038/5901158 Michael.Massing COVID19 COVID endothelial cardiovascular heart brain kidneys risk morbidity mortality https://twitter.com/ https://pinboard.in/u:Michael.Massing/b:6e7a6923a604/ 2018-09-14T04:16:17+00:00 https://www.uptodate.com/contents/glycemic-control-and-vascular-complications-in-type-2-diabetes-mellitus Michael.Massing type 2 T2D diabetes risk tight management glucose control blood benefit morbidity mortality microvascular complications kidneys eyes retinopathy nephropathy renal disease cardiovascular peer-reviewed research review meta-analysis overview in vivo situ human clinical trial symptoms comorbidities self treatment care https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:3e19f0b0c07b/ 2018-08-26T19:33:06+00:00 https://jamanetwork.com/journals/jama/article-abstract/2697696?widget=personalizedcontent&previousarticle=2697677 Michael.Massing cardiovascular heart brain risk health dementia benefit correlation peer-reviewed research human in situ cohort vivo https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:5dd3803ee86c/ 2018-07-19T01:57:14+00:00 https://www.cosmopolitan.com/health-fitness/news/a36957/can-a-sauna-session-count-as-a-workout/ Michael.Massing sauna bathing risk benefit cardiac cardiovascular morbidity mortality correlation human cohort prospective in vivo situ peer-reviewed research all-cause https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:83a3bfc5857d/ 2017-11-10T14:36:16+00:00 https://www.ncbi.nlm.nih.gov/pubmed/16670693 Michael.Massing GI glycemic index load GL carbohydrates vegetables fiber blood glucose lipids management risk diet self care peer-reviewed research zinc magnesium vitamin E supplements cholesterol harm reduction bran CHD cardiovascular protection in vivo human review overview stroke saelf B6 folate antioxidant https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:6cd67c146be7/ 2017-09-18T00:25:41+00:00 https://www.ncbi.nlm.nih.gov/pubmed/17992181 Michael.Massing risk benefit industrialized processed lipids vegetables cardiovascular blood whole grain fruit carbohydrate legumes glucose peer-reviewed research response insulin fiber comparison overview correlation type 2 T2D effect diet epidemiology etiology self care management long term short soluble insoluble metabolism prevention intact integrity diabetes cause factor factors https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:617bdbd5d015/ 2017-09-15T18:35:49+00:00 https://www.ncbi.nlm.nih.gov/pubmed/28035340 Michael.Massing hyperglycemia diabetes type 2 T2D blood glucose diet foods legumes berries sweet potatoes SMBG self care risk cardiovascular kidney neuropathy nephropathy chronic disease progression aging caloric calorie restriction acarbose metformin peak excursion spike peer-reviewed research target range management normal https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:aeb2a502e957/ 2017-09-15T12:25:32+00:00 https://www.ncbi.nlm.nih.gov/pubmed/16519037 Michael.Massing or =70% to the total glycemic load in patients who are fairly well controlled (HbA1c <7.3%). Furthermore, there is a linear relationship between the risk of CV death and the 2-hour oral glucose tolerance test (OGTT). Increased mortality is evident at OGTT levels of approximately 90 mg/dL (5 mmol/L), which is well below current definitions of type 2 diabetes. Biphasic insulin aspart was shown to be more effective at reducing HbA1c below currently recommended levels than basal insulin glargine (66% vs 40%; P < 0.001), and it reduced endothelial dysfunction more effectively than regular insulin (P < 0.01). Repaglinide achieved regression of carotid atherosclerosis (intima-media thickness) in 52% of patients versus 18% for glyburide (P < 0.01) over 1 year, although levels of HbA1c and CV risk factors were similar for both treatment groups. Finally, acarbose reduced the relative risk of CV events by 49% over 3.3 years versus placebo in patients with impaired glucose tolerance (2.2% vs 4.7%; P = 0.03) and by 35% over > or =1 year in patients with type 2 diabetes (9.4% vs 6.1%; P = 0.006). CONCLUSIONS: All components of the glucose triad (ie, FPG, HbA1c, and PPG) should be considered in the management of type 2 diabetes. Therapy targeted at PPG has been shown to improve glucose control and to reduce the progression of atherosclerosis and CV events; therefore, physicians should consider monitoring and targeting PPG, as well as HbA1c and FPG, in patients with type 2 diabetes.]]> hyperglycemia diabetes type 2 T2D blood glucose postprandial spike peak SMBG self care risk cardiovascular excursion damage vessel wall epithelial atherosclerosis morbidity mortality threshold peer-reviewed research prognostic target range management normal https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:369cb055d931/ 2017-09-15T02:56:27+00:00 https://www.ncbi.nlm.nih.gov/pubmed/12166606 Michael.Massing hyperglycemia diabetes type 2 T2D blood glucose postprandial spike peak SMBG self care risk cardiovascular excursion damage vessel wall epithelial atherosclerosis peer-reviewed research https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:28ce62ad71c8/ 2017-09-15T02:52:15+00:00 https://www.ncbi.nlm.nih.gov/pubmed/12166607 Michael.Massing40 mg/dl (2.2 mmol/l). As many as 70% of patients with an HbA1c <7% have PPG values >160 mg/dl (8.9 mmol/l) after meals. Fasting plasma glucose (FPG) is a poor indicator of plasma glucose at other times. The coefficient of correlation of FPG with plasma glucose at other times ranges from 0.50-0.70. Nor is the correlation of FPG with HbA1c very strong: in hundreds of determinations of HbA1c and FPG in our patients, the coefficient of correlation was not greater than 0.73. For the same FPG value, HbA1c varied markedly, and vice versa; further, the correlation between PPG and HbA1c was no higher than that between FPG and HbA1c (r = 0.65). Thus, monitoring in type 2 diabetes should include PPG along with FPG and HbA1c. Recent data provide direct and indirect evidence suggesting that PPG is independently related to cardiovascular disease (CVD), and supporting the idea that PPG should be assessed and glucose excursions with meals should be controlled: 1. Studies conducted by other investigators and ourselves in patients with type 2 diabetes have shown that the incidence of CVD is independently related to postprandial or post-OGTT (oral glucose tolerance test) blood glucose at baseline. In addition, data collected in the general population show an association between 2-hour OGTT plasma glucose (a surrogate of PPG) and cardiovascular morbidity and mortality that is independent of FPG. Also, subjects with impaired glucose tolerance (IGT) and isolated post-challenge hyperglycaemia have an increased cardiovascular risk over subjects with normal glucose tolerance (NGT). We found that IGT subjects had a risk of carotid stenosis 3-fold higher than subjects with NGT, even after adjustment for several confounders. Thus, a modest increase in post-OGTT plasma glucose and, by extrapolation, PPG seems to have a major detrimental effect on the arteries. 2. When FPG and/or HbA1c were the targets of glucose control in studies of patients with type 2 diabetes (the UGDP, VACSDM, and UKPDS) the effects on CVD were minimal. However, when the targets of glucose control included PPG (the Kumamoto Study and DIGAMI Study) favorable effects on CVD were observed. 3. There is experimental data suggesting that acute hyperglycaemia can exert deleterious effects on the arterial wall through mechanisms including oxidative stress, endothelial dysfunction, and activation of the coagulation cascade. This evidence prompted the European Diabetes Policy Group to set postprandial targets for blood glucose control: postprandial peaks should not exceed 135 mg/dl (7.5 mmol/ml) to reduce arterial risk and should not exceed 160 mg/dl (8.9 mmol/l) to reduce microvascular risk. Thus, glucose care in diabetes is not only "fasting glucose care" or "HbA1c care" but is also "postprandial glucose care."]]> hyperglycemia diabetes type 2 T2D blood glucose postprandial spike peak SMBG self care risk cardiovascular excursion peer-reviewed research target range management normal https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:625c5415bbe9/ 2017-09-10T22:46:23+00:00 http://blog.profil.com/blog/addressing-postprandial-glucose-excursion-what-is-the-evidence Michael.Massingblood glucose excursions SMBG pathophysiology circulation cardiovascular risk peak excursion spike peer-reviewed research https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:8af8785cf54f/ 2017-06-19T17:33:20+00:00 http://www.thedailybeast.com/the-heart-associations-junk-science-diet Michael.Massingscience diet saturated fats carbohydrates cardiovascular risk correlation criticism corruption https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:91484c81d95a/ 2017-01-03T21:54:54+00:00 http://www.npr.org/sections/goatsandsoda/2017/01/03/507562845/staying-fit-isnt-a-new-years-resolution-for-these-hunter-gatherers Michael.Massing fitness exercise activity lifestyle cardiac cardiovascular risk factor peer-reviewed research evolution human disease prevention population studies epidemiology blood pressure cholesterol earnest https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:77884855ed16/ 2016-12-07T03:18:22+00:00 http://www.reuters.com/article/us-eli-lilly-fda-idUSKBN13R2C3 Michael.Massing drug effects benefit treatment diabetes type 2 T2D cardiovascular heart risk morbidity mortality dcde https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:5cd350f0c2d6/ 2016-06-11T01:56:15+00:00 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781574/ Michael.Massing limb risk amputation PAD peripheral arterial disease clinical research human in vivo retrospective insulin sensitizer mimetic leg foot trial postmarket situ cardiovascular https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:3c3ee3aae5a0/ 2016-04-27T22:32:59+00:00 http://www.sciencedirect.com/science/article/pii/S1499267115008941 Michael.Massing risk food combinations patterns correlation cardiometabolic metabolic cardiovascular LDL cholesterol blood pressure pasta bread potatoes carbohydrates https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:6cd8cc5a44c5/ 2016-03-08T22:37:35+00:00 http://archinte.jamanetwork.com/article.aspx?articleid=1819573 Michael.Massingsugar risk heart disease cardiovascular intake peer-reviewed research Yang https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:8d9065e86879/ 2016-03-08T21:23:59+00:00 https://www.google.com/#newwindow=1&q=trans+fats+insulin+resistance+Lovejoy+risk+of+type+2+diabetes+obesity+Salmeron+cardiovascular+disease+heart+failure Michael.Massingtrans fats insulin resistance Lovejoy risk of type 2 diabetes obesity Salmeron cardiovascular disease heart failure https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:647d54af5afc/ 2016-02-14T23:57:55+00:00 https://www.sciencedaily.com/releases/2016/02/160209090616.htm Michael.Massing environment diet culture etiology diabetes contamination processed food foods PAMP pathogen associated molecular patterns earnest peer-reviewed research clinical trial in vivo human cardiovascular risk crossover industrialization correlation environmental factor public health cause factors https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:b975f61d7b84/ 2016-01-22T05:09:35+00:00 http://www.ncbi.nlm.nih.gov/pubmed/25185778 Michael.Massing lipids dyslipiodemia cholesterol blood fats correlation peer-reviewed research drug risk benefit statins cardiovascular https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:6910271cbac7/ 2015-08-16T21:14:56+00:00 http://www.nlm.nih.gov/medlineplus/ency/article/002470.htm Michael.Massing fiber food diet beans legumes self care treatment fruits vegetables benefit risk cardiovascular health weight control metabolism mineral absorption source supply peer-reviewed research clinical human in vivo body fat maintenance https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:8cef41b86157/ 2015-07-05T19:12:18+00:00 http://www.diabeticconnect.com/diabetes-information-articles/general/1975-detecting-type-2-diabetes-early-may-reduce-heart-disease-death-risk Michael.Massing diagnosis type 2 diabetes T2D prognostic morbidity prevention protection correlation peer-reviewed research heart cardiovascular dcde https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:73fabc1fcc83/ 2015-04-21T13:01:58+00:00 http://www.ncbi.nlm.nih.gov/pubmed/12556541 Michael.Massing diabetes type 2 T2D intensive treatment microalbuminaria multifactorial tight control multimodal risk complications late-stage symptoms comorbidities end-stage Danish 2003 human in vivo Denmark NEJM aggressive intervention benefit clinical trial self management cardiovascular nephropathy kidneys retinopathy neuropathy care peer-reviewed research microvascular situ blood glucose morbidity behavioral https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:477b4ec94a4f/ 2015-02-21T04:42:11+00:00 http://www.diabetes.org/research-and-practice/student-resources/history-of-diabetes.html Michael.Massing DCCT tight control diabetes .d2t complications late-stage symptoms risk benefit blood glucose sugar history timeline research peer-reviewed drug effects cardiovascular self-monitored self monitoring SMBG comorbidities late end-stage management treatment target range normal https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:08662e052464/ 2015-01-28T00:02:28+00:00 http://www.ncbi.nlm.nih.gov/pubmed/25198208 Michael.Massing remission peer-reviewed oil prevention CAD Esselstyn coronary reversal cardiovascular disease research diet artery earnest https://twitter.com/ https://pinboard.in/u:Michael.Massing/b:641d5b57fd4e/ 2014-12-20T19:36:15+00:00 http://www.medscape.com/viewarticle/836445 Michael.Massingpeer-reviewed research huan in vivo interventional sugar risk cardiovascular cardiometabolic salt https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:ba937c36df7b/ 2014-12-20T19:27:07+00:00 http://www.medscape.com/viewarticle/836490 Michael.Massing HDL niacin PLAY video risk marker factor drug supplement effects diabetogenic diabetes etiology adverse events bleeding cardiovascular infection myopathy lipids blood muscular cause https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:86bb9adadc90/ 2014-03-30T02:22:37+00:00 http://www.diabetesincontrol.com/index.php?option=com_content&task=view&id=16101&Itemid=8 Michael.Massing moderate wine alcohol use consumption type 2 diabetes benefit T2D risk dose-dependent correlation peer-reviewed research self care cardiovascular https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:9f00857aa30b/ 2014-02-24T01:46:18+00:00 http://www.sciencedaily.com/releases/2011/04/110411163803.htm Michael.Massing correlation peer-reviewed research wrist size skeletal mass density bone insulin resistance risk factor etiology diabetes type 2 T2D large frame BMI body circumference heart circulation cardiovascular cause chicken-and-egg https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:d459c156aece/ 2014-02-07T04:06:27+00:00 http://www.hsph.harvard.edu/news/magazine/secrets-of-sound-health/ Michael.Massing noise environment health risk peer-reviewed research stress cardiovascular aging children urban design technological public pollution fight-or-flight hospitalization https://twitter.com/ https://pinboard.in/u:Michael.Massing/b:d38adeb82dcf/ 2014-02-03T18:47:13+00:00 http://well.blogs.nytimes.com/2014/02/03/reaction-time-may-predict-longevity/?_php=true&_type=blogs&_php=true&_type=blogs&smid=tw-nytimeswell&seid=auto&_r=1 Michael.Massinglongevity correlation peer-reviewed research cardiovascular mortality all-cause https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:78fa0d458cfc/ 2014-01-12T02:19:44+00:00 http://www.diabetesincontrol.com/index.php?option=com_content&task=view&id=15695&Itemid=8 Michael.Massing diet correlation peer-reviewed research metabolic syndrome etiology high blood pressure cholesterol fats lipids overweight sodium salt alcohol glucose dysglycemia dyslipidemia self care intervention treatment fiber saturated fat polyunsaturated vitamin D cardiovascular risk hypertension diabetes cause factor https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:8aeb556198ed/ 2014-01-01T00:52:56+00:00 http://www.whfoods.com/genpage.php?tname=nutrient&dbid=112 Michael.Massingblood clotting vascular health calcification diatary sources vitamin K insulin resistance green vegetables leafy diet boner protection peer-reviewed research antioxidant anti-inflammatory inflammation neuroprotection neuroendocrine thyme tomatoes blueberries fermented soy cardiovascular heart circulation https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:e452a987426c/ 2013-10-24T02:07:02+00:00 http://www.nbcnews.com/health/strokes-increasing-among-young-people-study-finds-8C11453155 Michael.Massing youth diabetes stroke brain cardiovascular risk comorbidities https://twitter.com/ https://pinboard.in/u:Michael.Massing/b:2b6717287c48/ 2013-06-29T05:35:21+00:00 http://www.nejm.org/doi/full/10.1056/NEJMe1306987 Michael.Massing peer-reviewed research cardiovascular risk diabetes obesity human in vivo physical activity type 2 T2D correlation support treatment self care education depression comorbidities intensive lifestyle intervention retinopathy kidney disease hospitalization morbidity healthcare cost economics harm reduction behavioral change management behavior tight control exercise body fat clinical trial stress distress factor therapy etiology mitigation prevention symptoms late-stage complications benefit situ cause https://pinboard.in/u:Michael.Massing/b:61128166265a/ 2013-06-23T19:23:33+00:00 http://well.blogs.nytimes.com/2013/06/17/cheating-ourselves-of-sleep/?smid=tw-share Michael.Massing research overview T2D diabetes type 2 human in vivo cardiovascular risk effects sleep deficit peer-reviewed clinical trial prediabetes https://pinboard.in/u:Michael.Massing/b:760838ee5f64/ 2013-06-10T17:30:57+00:00 http://www.diabetesincontrol.com/index.php?option=com_content&task=view&id=14722&Itemid=8 Michael.Massingrisk population major diabetes hypoglycemia peer-reviewed research clinical medical cardiovascular vascular https://pinboard.in/u:Michael.Massing/b:d63d5ef94435/ 2013-06-08T21:19:48+00:00 http://j.mp/13mnRtz Michael.Massing treatment hyperlipidemia standard of care cholesterol cardiovascular risk adverse effect drug statin peer-reviewed research correlation earnest human in vivo large cohort T2D diabetes type 2 statins effects clinical trial https://pinboard.in/u:Michael.Massing/b:5898b49891db/ 2013-06-08T18:16:50+00:00 http://www.diabetesincontrol.com/index.php?option=com_content&task=view&id=14727&Itemid=8 Michael.Massing coffee weight loss body fat metabolism protection dose dose-dependent effects risk benefit drug earnest peer-reviewed research in vivo prevention T2D cardiovascular correlation type 2 diabetes insulin resistance diet https://pinboard.in/u:Michael.Massing/b:1f6d0c451c59/ 2013-04-30T03:54:55+00:00 https://www.google.com/search?q=risk%20midlife%20factors%20lifetime%20heart%20disease Michael.Massingrisk midlife lifetime heart disease cardiovascular etiology factor https://pinboard.in/u:Michael.Massing/b:cc7d9c2625e6/ 2013-03-05T02:32:43+00:00 http://www.diabetesincontrol.com/index.php?option=com_content&task=view&id=12008&Itemid=8 Michael.Massing medical research peer-reviewed human in vivo macular degeneration aspirin risk benefit drug intervention prevention cardiovascular correlation clinical trial https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:b54505ac9898/ 2012-06-27T14:31:04+00:00 http://scholar.google.com/scholar?q=SSRI+cardiovascular+risk&btnG=&hl=en&as_sdt=0%2C5&as_vis=1 Michael.MassingSSRI cardiovascular risk medical research https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:9eed3b24d2a0/ 2012-04-02T06:25:49+00:00 http://www.diabetesselfmanagement.com/Blog/Diane-Fennell/adequate-sleep-vital-for-heart-health/ Michael.Massing medical research poster sleep cardiovascular risk diabetes T2D type 2 human in vivo correlation preliminary results clinical trial https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:479858b86b1f/ 2012-03-04T03:39:39+00:00 http://www.dlife.com/diabetes-news/content/heart-healthy-choices-early-pay-later Michael.Massing risk reduction mitigation cardiovascular heart circulation self care prevention medical research peer-reviewed BMI body fat weight correlation factor https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:f80f19b62e1c/ 2012-02-28T21:26:16+00:00 http://www.nytimes.com/2012/02/28/health/research/diet-soft-drinks-linked-to-risk-of-heart-disease.html?src=recg Michael.Massing medical research peer-reviewed risk mortality morbidity diabetes diet cardiovascular stroke heart circulation brain disease epidemiology soda pop soft drinks hatmandu correlation factor etiology cause https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:c27ca63274d0/ 2012-02-27T23:28:42+00:00 http://pinboard.in/u:Michael.Massing/t:plastics/ Michael.Massing morbidity mortality risk diabetes cardiovascular environment pollution endocrine ocean outbasket child development diet outbox poison etiology correlation factor T2D type 2 environmental plastics disruptor cause factors https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:56da5c18e89f/ 2012-02-27T01:16:50+00:00 http://www.diabetesincontrol.com/index.php?option=com_content&task=view&id=12191&Itemid=8 Michael.Massing diabetes mortality insulin drug effects risk bad science peer-reviewed end-stage renal disease coronary artery MODY ESRD CAD cardiovascular heart circulation kidney results intervention over-treatment medical research correlation benefit https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:d10faddd7c5b/ 2012-02-26T19:53:18+00:00 http://www.diabetesincontrol.com/index.php?option=com_content&task=view&id=12193&Itemid=8 Michael.Massing child development exercise prevention mitigation risk cardiovascular heart circulation parenting waist circumference blood pressure triglycerides HDL cholesterol insulin belly fat medical research peer-reviewed metabolism physical activity screen time public health prognostic markers data children youth behavior self care correlation factor hypertension high treatment https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:8fffb6fa84b0/ 2012-02-21T06:46:15+00:00 http://www.nytimes.com/2012/01/17/health/depression-defies-rush-to-find-evolutionary-upside.html?_r=4&ref=science Michael.Massing disability morbidity mortality risk depression evolution theory comorbidities brain medical research hippocampus cardiovascular mental health illness chronic hatmandu earnest https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:21a6b6dcb1a4/ 2012-02-21T02:42:04+00:00 http://www.diabetesincontrol.com/index.php?option=com_content&task=view&id=12164&Itemid=8 Michael.Massing risk fitness fatness body fat cardiovascular hypertension high blood pressure metabolic syndrome hyperlipidemia cholesterol LDL attenuation mitigation self care weight loss gain independent variables what.I'm.reading medical research peer-reviewed hatmandu earnest T2D diabetes correlation factor etiology cause https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:0e6936aaf6f6/ 2012-02-18T02:47:44+00:00 http://www.dlife.com/diabetes-news/content/elevated-glucose-associated-undetected-heart-damage Michael.Massing risk morbidity mortality atherosclerosis blood vessel damage glucose sugar high dysglycemia hyperglycemia prognostic medical research in vivo human peer-reviewed hemoglobin A1c marker heart cardiovascular correlation diagnosis clinical trial threshold diabetes https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:abbc29e88446/ 2012-02-10T21:31:35+00:00 http://www.diabetesselfmanagement.com/Blog/David-Spero/what-causes-diabetes-fatigue/ Michael.Massing diabetes fatigue symptoms aging blood glucose drug effects endocrine testosterone infection risk depression comorbidities circadian clock rhythms biological carbohydrates sleep stress benefit hydration heart cardiovascular disease circulation T2D type 2 research human in vivo exercise physical activity correlation clinical trial distress factor etiology cause https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:6721ec2019ad/ 2012-02-08T05:04:47+00:00 http://www.dlife.com/diabetes-news/content/sleep-problems-increase-risk-cardiovascular-disease-diabetes-and-obesity-penn-study-shows Michael.Massing medical research peer-reviewed sleep risk benefit cardiovascular diabetes obesity disease morbidity mortality David.E hatmandu earnest T2D type 2 human in vivo correlation clinical trial https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:01c6861c89e9/ 2012-01-20T03:30:50+00:00 http://www.dlife.com/diabetes-news/content/vitamin-d-could-combat-effects-aging-eyes Michael.Massing amyloid beta Alzheimer's what.I'm.reading eyes supplements vitamin cardiovascular heart circulation pathology improvement D diet sunlight evolution human prevention protection brain macular degeneration medical research peer-reviewed disease neuroprotection cognition dementia T2D diabetes correlation insulin neuroendocrine risk inflammation resistance neurotransmitter type 2 3 blood glucose sugar fats lipids https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:525b476648f2/ 2012-01-19T01:32:16+00:00 http://news.yahoo.com/blogs/this-could-be-big-abc-news/ultimate-example-preventive-medicine-232140727.html Michael.Massing health care economics prevention risk benefit cost supplements diet food schedule regularity predictability stress hormones good fats cardiovascular heart circulation Bill Weir David Agus eggs earnest meal planning https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:ea6995fc1aa4/ 2012-01-15T03:10:12+00:00 http://www.diabetesincontrol.com/index.php?option=com_content&task=view&id=12006&Itemid=8 Michael.Massing C-reactive protein biomarker cardiovascular disease marker indicator medical research peer-reviewed risk benefit vitamin D supplements dosage serum concentration correlation https://pinboard.in/ https://pinboard.in/u:Michael.Massing/b:ca67275cc5e8/